Literature DB >> 15105800

Male hormonal contraception.

Christina Wang1, Ronald S Swerdloff.   

Abstract

Male hormonal contraception, based on the suppression of both gonadotropins, follicle-stimulating hormone and luteinizing hormone, resulting in marked decrease in sperm production, is designed for couples in stable relationships where the male partner desires to assume family planning responsibilities using reversible methods. Two large scale, multicenter studies that used testosterone injections as the prototype male hormonal contraceptive demonstrated when azoospermia and/or very severe oligozoospermia were attained, contraceptive efficacy was equivalent to female hormonal methods. Current studies aim to find the androgen alone or androgen plus progestin preparations that are most efficacious, user friendly, and with least potential adverse effects. It is likely that injections or implants of androgens either alone or with progestins will become the first male hormonal contraceptive available within this decade. Further research and development include the use of selective androgen and/or progestin receptor modulators, nonpeptide GnRH antagonists, and agents with local actions on the testis for male contraception.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105800     DOI: 10.1016/j.ajog.2004.01.057

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

Review 1.  Discovery and therapeutic promise of selective androgen receptor modulators.

Authors:  Jiyun Chen; Juhyun Kim; James T Dalton
Journal:  Mol Interv       Date:  2005-06

Review 2.  Male hormonal contraception: potential risks and benefits.

Authors:  Niloufar Ilani; Ronald S Swerdloff; Christina Wang
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

3.  Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive.

Authors:  Prasanth Surampudi; Stephanie T Page; Ronald S Swerdloff; Jean Jacques Nya-Ngatchou; Peter Y Liu; John K Amory; Andrew Leung; Laura Hull; Diana L Blithe; Jason Woo; William J Bremner; Christina Wang
Journal:  Andrology       Date:  2014-05-02       Impact factor: 3.842

Review 4.  Does ethnicity matter in male hormonal contraceptive efficacy?

Authors:  Niloufar Ilani; Peter Y Liu; Ronald S Swerdloff; Christina Wang
Journal:  Asian J Androl       Date:  2011-02-14       Impact factor: 3.285

Review 5.  Hormonal approaches to male contraception.

Authors:  Christina Wang; Ronald S Swerdloff
Journal:  Curr Opin Urol       Date:  2010-11       Impact factor: 2.309

6.  Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.

Authors:  Vahid Mahabadi; John K Amory; Ronald S Swerdloff; William J Bremner; Stephanie T Page; Regine Sitruk-Ware; Peter D Christensen; Narender Kumar; Yun-Yen Tsong; Diana Blithe; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

7.  Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men.

Authors:  Fiona Yuen; Arthi Thirumalai; Cindy Pham; Ronald S Swerdloff; Bradley D Anawalt; Peter Y Liu; John K Amory; William J Bremner; Clint Dart; Hongsheng Wu; Laura Hull; Diana L Blithe; Jill Long; Christina Wang; Stephanie T Page
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

8.  Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male Pill.

Authors:  Arthi Thirumalai; Jonas Ceponis; John K Amory; Ronald Swerdloff; Vijaya Surampudi; Peter Y Liu; William J Bremner; Eric Harvey; Diana L Blithe; Min S Lee; Laura Hull; Christina Wang; Stephanie T Page
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

9.  Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.

Authors:  Peter Y Liu; Ronald S Swerdloff; Bradley D Anawalt; Richard A Anderson; William J Bremner; Joerg Elliesen; Yi-Qun Gu; Wendy M Kersemaekers; Robert I McLachlan; M Cristina Meriggiola; Eberhard Nieschlag; Regine Sitruk-Ware; Kirsten Vogelsong; Xing-Hai Wang; Frederick C W Wu; Michael Zitzmann; David J Handelsman; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2008-02-26       Impact factor: 5.958

10.  A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.

Authors:  Niloufar Ilani; Mara Y Roth; John K Amory; Ronald S Swerdloff; Clint Dart; Stephanie T Page; William J Bremner; Regine Sitruk-Ware; Narender Kumar; Diana L Blithe; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2012-07-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.